Belgium – Research and development services and related consultancy services – Speed up the development of and access to innovative medical countermeasures - Point of care metagenomic sequencing for universal pathogen detection.
closedHealth and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency · HADEA
Value
€24m
Published
21 May 2024
Deadline
—
Type
opportunity
73000000 · Research & development services73300000 · Research & development services
Description
This procedure supports the development of a metagenomic next-generation sequencing (mNGS)-based test that can detect any respiratory/airborne viral pathogen, including novel and emerging, from any human respiratory sample type.
Key facts
- Procedure
- neg-w-call
- Submit via
- https://webgate.ec.europa.eu/digit/opsys/esubmission?cftUuid=dd767397-1a4c-44fc-9d8e-b729898b5aba
- Contact
- hadea-procell@ec.europa.eu
- Category
- services
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 297279-2024
- First seen
- 24 Aug 2026
- Last updated
- 28 Aug 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/39669251-22db-4b66-bd6f-1144231d3cfdThe source notice is authoritative — verify deadlines and documents there before bidding.